Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

Keywords

Monoclonal antibody, Pathology, Immunoperoxidase, Antigen, Fibroadenoma

References

• Monoclonal antibodies reactive with breast tumor-associated antigens.Jeffrey Schlom, David Colcher, Patricia Horan Hand — 1985
• Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation.Donald Küfe, L M Nadler, Lalla Sargent — 1983
• Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.Patricia Horan Hand, Marianna Nuti, David Colcher — 1983
• Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancersJ. Arklie, Joyce Taylor‐Papadimitriou, Walter F. Bodmer — 1981
• Use of monoclonal antibodies for the histopathological diagnosis of human malignancyKC Gatter, Z. Abdulaziz, Peter C. L. Beverley — 1982
• Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathologyJ P Sloane, M.G. Ormerod — 1981
• A spectrum of monoclonal antibodies reactive with human mammary tumor cells.David Colcher, Patricia Horan Hand, Marianna Nuti — 1981
• Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.A. A. Epenetos, G Canti, Joyce Taylor‐Papadimitriou — 1982
• A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor‐associated antigen in human mammary carcinoma cell populationsMarianna Nuti, Y A Teramoto, Renato Mariani‐Costantini — 1982
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.S M Hsu, Laurence Raine, Herbert Fanger — 1981
• Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions.A To, D. V. Coleman, David P. Dearnaley — 1981
• Differential binding to human mammary and nonmammary tumors of monoclonal antibodies reactive with carcinoembryonic antigen.David Colcher, Patricia Horan Hand, Marianna Nuti — 1983
• Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours.A. A. Epenetos, S. J. Mather, M. Granowska — 1982
• Monoclonal antibodies to epithelium‐specific components of the human milk fat globule membrane: Production and reaction with cells in cultureJoyce Taylor‐Papadimitriou, Jerry A. Peterson, J. Arklie — 1981
• Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.Sylvie Ménard, Elda Tagliabue, Silvana Canevari — 1983
• Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22.Croghan Ga, Papsidero Ld, Valenzuela La — 1983
• Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma.Lawrence D. Papsidero, Gary A. Croghan, Mary Jane O'Connell — 1983
• A human breast tissue-associated antigen detected by a monoclonal antibody.Thompson Ch, Jones Sl, R. H. Whitehead — 1983

Cited by

• CA 15.3 in Nonmalignant Liver DiseasesCecile Moussa — 1991
• Monoclonal antibodies reactive with human breast or ovarian carcinoma: in vivo applications.Emir Rodríguez Monegal — 1989
• Murine monoclonal antibodies in breast cancer: An overviewЛюдмила Федоровна Лебедева — 1988
• CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancerJames Bonner — 1995
• Fast skeletal muscle troponin T increases the cooperativity of transgenic mouse cardiac muscle contractionJoseluís González — 1999
• Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA)Gérard Barbeau, Christian Asselin — 2002
• Serum tumor markers in the management of ovarian, endometrial and cervical cancer.Carlos Padilla Carmona — 2004
• Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues.Rolf Oppliger — 2006
• Expression of tumor-associated differentiation antigens, MUC1 glycoforms and CEA, in human thymic epithelial cells: implications for self-tolerance and tumor therapy.Justo Formentín Ibáñez — 2007
• Nuclear Import of the MUC1-C Oncoprotein Is Mediated by Nucleoporin Nup62*彰規 渡辺 — 2007
• Current immunotherapeutic strategies in pancreatic cancer.隆之 鳥山, 公一 北原, 智浩 原田 — 2007
• Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancerMarta García Alonso — 2009
• Altered intracellular region of MUC1 and disrupted correlation of polarity-related molecules in breast cancer subtypesPaolo Salandin, Andrea Rinaldo — 2015
• Glycosylation Changes in Brain CancerFabiola Altimari Montiel — 2017
• Specificity and utility of SubB2M, a new N-glycolylneuraminic acid lectin.Горева Татьяна Игоревна, Портнягин Николай Николаевич, Пюкке Георгий Александрович — 2018
• Study of serum tumor markers CEA, CA 15.3 and CA 27.29 as diagnostic parameters in patients with breast carcinomaLeonard Paterna, F. Melgar Arnaiz, J Esténoz — 1995
• MHC-UNRESTRICTED MUC1-SPECIFIC T CELL RECEPTOR FOR CANCER IMMUNOTHERAPY/GENE THERAPYNehad M. Alajez — 2003
• Quantification of MUC1 in breast cancer patients. A method comparison study.Gijsbert G. Bon, Gerard J. van Kamp, Rob A. Verstraeten — 1999
• Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.Debasish Tripathy, Christopher C. Benz — 1992
• Massenspektrometrische Untersuchungen von modifizierten Nucleosiden und ihre Evaluierung als Tumormarker bei BrustkrebsAntje Frickenschmidt — 2006

Related papers

• The expression of telomerase gene hTR in breast carcinoma tissuesJiabu Tang, Zhu Rui-qing, Xiaoyi Chen — 2004
• Expressions and significances of CKS1 and CyclinD1 in breast carcinomaQuanyi Wang — 2013
• Detection of Telomerase Activity in Human Breast Carcinoma and Its SignificanceWu Jian — 2003
• An Evaluation of Potentially Suitable Fixatives for Immunoperoxidase Staining of Estrogen Receptors in Imprints and Frozen Sections of Breast CarcinomaWendy A. Raymond, Anthony S.‐Y. Leong — 1988
• The Clinical Significance of P16 Protein Expression in Breast CarcinomaWu Jian — 2003
• Benign disease of the breast in Ile-Ife: a 10 year experience and literature review.KA Adeniji, KA Adelusola, W O Odesanmi — 1997
• Risk Factors for breast cancer from benign breast disease in a diverse populationMaria J. Worsham, Usha Raju, Mei Lü — 2008
• Benign breast disease in women of Hazara DivisionAnila Riyaz, Shagufta Naeem, Shabana Naz — 2019
• THE CURRENT SCENARIO OF BENIGN BREAST DISEASES IN RURAL INDIA. A CLINICOPATHOLOGICAL STUDYPawan Tiwari, Madhu Tiwari — 2013